SCHEMBL911180

SCHEMBL911180

COc1ccc(F)c2sncc12

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NQO1 P15559 1/20 0.33
ALDH1A1 P00352 2/20 0.33
RAB9A P51151 2/20 0.33
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
NPC1 O15118 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
PDGFRB P09619 2/20 0.32
PDGFRA P16234 2/20 0.32
LMNA P02545 1/20 0.32
MAPK1 P28482 1/20 0.32
HTT P42858 1/20 0.32
IDO1 P14902 2/20 0.32
TUBB1 Q9H4B7 1/20 0.31
PTGS2 P35354 1/20 0.31
FLT1 P17948 1/20 0.31
EP300 Q09472 1/20 0.31
KAT8 Q9H7Z6 1/20 0.31
TRPA1 O75762 2/20 0.31
PKM P14618 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4799941 0.80 ALDH1A1 (0.38) NQO1ALDH1A1SMN1; SMN2LMNAIDO1
SCHEMBL4801476 0.79 NQO2 (0.38) NQO1ALDH1A1MEN1KMT2AIDO1
SCHEMBL11470037 0.79 IDO1 (0.47) NQO1ALDH1A1RAB9AMEN1KMT2A
SCHEMBL4803585 0.70 MAPT (0.43) NQO1ALDH1A1RAB9AMEN1KMT2A
SCHEMBL19435542 0.70 MAPT (0.42) NQO1ALDH1A1RAB9AMEN1KMT2A
SCHEMBL291713 0.67 ALDH1A1 (0.42) ALDH1A1RAB9AMEN1KMT2ANPC1
SCHEMBL4804570 0.65 GRM1 (0.35) NQO1ALDH1A1RAB9AMEN1KMT2A
SCHEMBL485265 0.65 IDO1 (0.57) NQO1ALDH1A1MEN1KMT2ASMN1; SMN2
SCHEMBL20305437 0.64 ALDH1A1 (0.40) ALDH1A1RAB9AMEN1KMT2ANPC1
SCHEMBL19435489 0.64 CYP19A1 (0.38) ALDH1A1MEN1KMT2AMAPK1IDO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7868017-B2 9-azabicyclo[3.3.1]nonane derivatives N.V. ORGANON (NL) 2011-01-11 US disclosed
US-7868017-B2 9-azabicyclo[3.3.1]nonane derivatives N.V. ORGANON (NL) 2011-01-11 US disclosed
US-7868017-B2 9-azabicyclo[3.3.1]nonane derivatives N.V. ORGANON (NL) 2011-01-11 US disclosed
EP-1934212-A1 9-AZABICYCLO [3 . 3 . 1]NONANE DERIVATIVES AS MONOAMINE REUPTAKE INHIBITORS N.V. Organon (NL) 2008-06-25 EP disclosed
US-20070112019-A1 9-Azabicyclo[3.3.1]nonane derivatives N.V. ORGANON (NL) 2007-05-17 US disclosed
US-20070112019-A1 9-Azabicyclo[3.3.1]nonane derivatives N.V. ORGANON (NL) 2007-05-17 US disclosed
US-20070112019-A1 9-Azabicyclo[3.3.1]nonane derivatives N.V. ORGANON (NL) 2007-05-17 US disclosed
WO-2007039563-A1 9-AZABICYCLO [3 . 3 . 1] NONANE DERIVATIVES AS MONOAMINE REUPTAKE INHIBITORS N.V. ORGANON (NL) 2007-04-12 WO disclosed
WO-2007039563-A1 9-AZABICYCLO [3 . 3 . 1] NONANE DERIVATIVES AS MONOAMINE REUPTAKE INHIBITORS N.V. ORGANON (NL) 2007-04-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070112019-A1 9-Azabicyclo[3.3.1]nonane derivatives AZI2, TPMT, TET3 NQO1 1404/4885ALDH1A1 441/4885RAB9A 298/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.